Risk factors for neonatal conjunctivitis in babies of HIV-1 infected mothers

REFERENCES

• Gilbert C, Foster A.Childhood blindness in the context of VISION 2020 – The Right to Sight. Bull World Health Organ 2001;79(3):227–232.
   PubMed Web of Science ®Google Scholar
• Fransen L, Klauss V. Neonatal ophthalmia in the developing world. Epidemiology, etiology, management and control. Int Ophthalmol 1988;11(3):189–196.
   PubMedGoogle Scholar
• Verma M, Chhatwal J, Varughese PV. Neonatal conjunctivitis: a profile. Indian Pediatr 1994;31(11):1357–1361.
   PubMedGoogle Scholar
• Woods CR. Gonococcal infections in neonates and young children. Semin Pediatr Infect Dis 2005;16(4):258–270.
   PubMedGoogle Scholar
• Zar JH. Neonatal chlamydia infections, prevention and treatment. Pediatr Drugs 2005;7(2):103–110.
   PubMedGoogle Scholar
• Nahmias AJ, Visintine AM, Caldwell DR, Wilson LA. Eye infections with herpes simplex viruses in neonates. Surv Ophthalmol 1976;21(2):100–105.
   PubMedGoogle Scholar
• Sahu DN, Thomson S, Salam A, Morton G, Hodgkins P. Neonatal methicillin resistant staphylococcus aureus conjunctivitis. Br J Ophthalmol 2006;90(6):794–795.
   PubMedGoogle Scholar
• Fiorito SM, Galarza PG, Sparo M, Pagano EI, Oviedo CI. An unusual transmission of Neisseria meningitidis: neonatal conjunctivitis acquired at delivery from the mother’s endocervical infection. Sex Transm Dis 2001;28(1):29–32.
   PubMedGoogle Scholar
• Poschl JB, Hellstern G, Ruef P, Bauer J, Linderkamp O. Ophthalmia Neonatorum caused by Group B Streptococcus. Scand J Infect Dis 2002;34(12):921–922.
   PubMedGoogle Scholar
• Bartolomeo SD, Mirta DH, Janer M, Fermepin MR, Sauka D, Magarinos F, de Torres RA. Incidence of Chlamydia trachomatis and other potential pathogens in neonatal conjunctivitis. Int J Infect Dis 2001;5(3):139–143.
   PubMedGoogle Scholar
• Armstrong JH, Zacarias F, Rein MF. Ophthalmia neonatorum: a chart review.Pediatrics 1976;57(6):884–892.
   PubMedGoogle Scholar
• Mohile M, Deorari AK, Satpathy G, Sharma A, Singh M. Microbiological study of neonatal conjunctivitis with special reference to Chlamydia trachomatis. Indian J Ophthalmol 2002;50(4):295–299.
   PubMedGoogle Scholar
• Dogru M, Karakaya H, Baykara M, özmen A, Koksal N, Goto E, Matsumoto Y, Kojima T, Shimazaki J, Tsubota K. Tear function and ocular surface findings in premature and term babies. Ophthalmology 2004;111(5):901–905.
   PubMedGoogle Scholar
• Shariat H, Young M, Abedin M. An interesting case presentation: a possible new route for perinatal acquisition of Chlamydia. J Perinatol 1992;12(3):300–302.
   PubMedGoogle Scholar
• Plummer FA, Laga M, Brunham RC, Piot P, Ronald AR, Bhullar V, Mati JY, Ndinya-Achola JO, Cheang M, Nsanze H. Post-partum upper genital tract infections in Nairobi, Kenya: epidemiology, etiology and risk factors. J Infect Dis 1987;156(1):92–98.
   PubMedGoogle Scholar
• Tjia KF, van Putten JPM, Pels E, Zanen HC. The interaction between Neisseria gonorrheae and the human cornea in organ culture. An electron microscopic study. Graefes Arch Clin Exp Ophthalmol 1988;226(4):341–345.
   PubMedGoogle Scholar
• Chandler JW, Milam DF. Diphtheria corneal ulcers. Arch Ophthalmol 1978;96(1):53–56.
   PubMedGoogle Scholar
• Fleiszig SMJ, Zaidi TS, Fletcher EL, Preston MJ, Pier GB. Pseudomonas aureginosa invades corneal epithelial cells during experimental infection. Infect Immun 1994;62(8):3485–3493.
   PubMedGoogle Scholar
• Labrec EH, Schneider H. Magnani TJ, Formal SB. Epithelial cell penetration as an essential step in the pathogenesis of bacillary dysentery. J Bacteriol 1964;88(5):1503–1518.
   PubMedGoogle Scholar
• McClelland RS, Baeten JM. Reducing HIV-1 transmission through prevention strategies targeting HIV-1-seropositive individuals. J Antimicrob Chemother 2006;57(2):163–166.
   PubMedGoogle Scholar
• McClelland RS, Lavreys L, Katingima C, Overbaugh J, Chohan V, Mandaliya K, Ndinya-Achola J, Baeten JM. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis 2005;191(3):333–338.
   PubMedGoogle Scholar
• Dennehy P, Warman R, Flynn JT, Scott GB, Mastrucci MT. Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107(7):978–982.
   PubMedGoogle Scholar
• Ikoona E, Kalyesubula I, Kawuma M. Ocular manifestations in paediatric HIV/AIDS in Mulago Hospital, Uganda. Afr Health Sci 2003;3(2):83–86.
   PubMedGoogle Scholar
• Shaffer N, Chuachoowong R, Mock PA, Bhadrakom C, Siriwasin W, Young NL, Chotpitayasunondh T, Chearskul S, Roongpisuthipong A, Chinayon P, Karon J, Mastro TD, Simonds RJ, on behalf of the Bangkok Collaborative Perinatal HIV Transmission Study Group. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999;353(9155):773–780.
   PubMedGoogle Scholar
• Wiktor SZ, Ekpini E, Karon JM, Nkengasong J, Maurice C, Severin ST, Roels TH, Kouassi MK, Lackritz EM, Coulibaly IM, Greenberg AE. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d’Ivoire: a randomised trial. Lancet 1999:353(9155):781–785.
   PubMedGoogle Scholar
• Panteleeff DD, Emery S, Richardson BA, Rousseau C, Benki S, Bodrug S, Kreiss JK, and Overbaugh J. Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples. J Clin Microbiol 2002;40(11):3929–3937.
   PubMedGoogle Scholar
• Panteleeff DD, John GC, Nduati R, Mbori-Ngacha D, Richardson BA, Kreiss JK, and Overbaugh J. Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA. J Clin Microbiol 1999;37(2):350–353.
   PubMedGoogle Scholar
• Laga M, Plummer FA, Nzanze H, et al. Epidemiology of ophthalmia neonatorum in Kenya. Lancet 1986;2(8516):1145–1149.
   PubMedGoogle Scholar
• Mabey D, Hanlon P, Hanlon L, Marsh V, Forsey T. Chlamydial and gonococcal ophthalmia neonatorum in The Gambia. Ann Trop Paediatr 1987;7(3):177–180.
   PubMedGoogle Scholar
• Matinzadeh ZK, Beiragdar F, Kavemanesh Z, Abolgasemi H, Amirsalari S. Efficacy of topical ophthalmic prophylaxis in prevention of ophthalmia neonatorum. Trop Doct 2007;37(1):47–49.
   PubMedGoogle Scholar
• Fredricks DN, Fiedler TL, Marrazzo JM. Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med 2005;353(18):1899–1911.
   PubMedGoogle Scholar
• McDonald HM, Brocklehurst P, Gordon A. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev 2007;24(1):CD000262.
   Google Scholar
• Jamieson DJ, Duerr A, Klein RS, Paramsothy P, Brown W, Cu-Uvin S, Rompalo A, Sobel J. Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study. Obstet Gynecol 2001; 98(4):656–663.
   PubMedGoogle Scholar
• Chen JY. Prophylaxis of ophthalmia neonatorum: comparison of silver nitrate, tetracycline, erythromycin and no prophylaxis. Pediatr Infect Dis J 1992;11(12):1026–1030.
   PubMedGoogle Scholar
• Isenberg SJ, Apt L, Wood M. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 1995;332(9):562–566.
   PubMedGoogle Scholar
• Isenberg SJ, Apt L, Del Signore M, Gichuhi S, Berman NG. A double application approach to ophthalmia neonatorum prophylaxis. Br J Ophthalmol 2003;87(12):1449–1452.
   PubMedGoogle Scholar
• Kapoor VS, Whyte R, LaRoche RR. Interventions for preventing ophthalmia neonatorum (Protocol). Cochrane Database Syst Rev 1999;(4): CD001862.
   Google Scholar